← Leaderboards
William Garrow Kerr
University Of South Florida
$11,380,338
Attributed
$13,986,405
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$13,986,405 · 9
By mechanism
R01$8,702,264 · 4
RF1$3,909,100 · 1
R21$1,150,041 · 3
R41$225,000 · 1
Top collaborators
- Steven Estus2 shared
- Mary Beth Humphrey2 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Tomar Ghansah$396,867
- Piyush Koria$1,069,080
Others in their field
Top investigators on “Bone Marrow Transplantation”
- Charles A Coltman · Southwest Oncology Group$143,196,322
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Richard L Schilsky · University Of Chicago$50,742,272
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,601,153
- Kenneth C Anderson · Dana-Farber Cancer Inst$34,098,561
- Bruce R. Blazar · University Of Minnesota$32,866,133
Research focus
Bone Marrow TransplantationGenesImmuneBaseIn VivoMolecularAllogenicCellsPlayPreventReceptor ExpressionInhibitor/AntagonistNatural Killer CellsLeadResponseSignal PathwaySignal TransductionNeoplastic CellProductionProteinsGraft-Vs-Host DiseaseGenetically Modified AnimalsHuman Fetus TissueClinical Research
Grant awards (40)
Novel and potent SHIP1 inhibitors for improving hematologic recovery following myelosuppressive therapies$225,000
R41 · FY2019 · HL · contact PI
Translating SHIP1 Genetics to Generate a Novel Alzheimers Pharmacologic Agent$118,080
RF1 · FY2019 · AG
Translating SHIP1 genetics to generate a novel Alzheimer's pharmacologic agent$3,791,020
RF1 · FY2018 · AG
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation$399,982
R01 · FY2014 · HL · contact PI
Role of SHIP in NK Cell Biology$275,952
R01 · FY2014 · HL · contact PI
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation$390,931
R01 · FY2013 · HL · contact PI
Role of SHIP in NK Cell Biology$268,067
R01 · FY2013 · HL · contact PI
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation$413,185
R01 · FY2012 · HL · contact PI
Role of SHIP in NK Cell Biology$281,583
R01 · FY2012 · HL · contact PI
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation$427,619
R01 · FY2011 · HL · contact PI
Role of SHIP in NK Cell Biology$422,367
R01 · FY2011 · HL · contact PI
SHIP and Immunoregulatory Cell Function$355,750
R01 · FY2011 · HL · contact PI
Role of SHIP in NK Cell Biology$392,500
R01 · FY2010 · HL · contact PI
SHIP and Immunoregulatory Cell Function$355,750
R01 · FY2010 · HL · contact PI
Role of SHIP in NK Cell Biology$406,750
R01 · FY2009 · HL · contact PI
SHIP and Immunoregulatory Cell Function$370,000
R01 · FY2009 · HL · contact PI
Role of SHIP in NK Cell Biology$410,500
R01 · FY2008 · HL · contact PI
SHIP and Immunoregulatory Cell Function$388,333
R01 · FY2008 · HL · contact PI
Defining the Multiple Myeloma Kinome$157,165
R21 · FY2008 · CA · contact PI
The Kinomes of Non-Hodgkin Lymphoma$132,379
R21 · FY2008 · CA · contact PI
The Kinomes of Non-Hodgkin Lymphoma$23,920
R21 · FY2008 · CA · contact PI
Defining the Multiple Myeloma Kinome$5,299
R21 · FY2008 · CA · contact PI
Role of SHIP in NK Cell Biology$427,000
R01 · FY2007 · HL · contact PI
Defining the Multiple Myeloma Kinome$214,114
R21 · FY2007 · CA · contact PI
The Kinomes of Non-Hodgkin Lymphoma$195,600
R21 · FY2007 · CA · contact PI
The Hematopoietic Kinome$182,198
R21 · FY2006 · DK · contact PI
Role of SHIP in Control of NK Cell Function$406,516
R01 · FY2005 · HL
The Hematopoietic Kinome$239,366
R21 · FY2005 · DK
Role of SHIP in Control of NK Cell Function$406,516
R01 · FY2004 · HL
Role of SHIP in Control of NK Cell Function$57,007
R01 · FY2004 · HL
Role of SHIP in Control of NK Cell Function$290,000
R01 · FY2003 · HL
C-MPL AND EARLY HUMAN HEMATOPOIESIS$262,322
R01 · FY2003 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$24,176
R01 · FY2003 · DK
Role of SHIP in Control of NK Cell Function$290,000
R01 · FY2002 · HL
C-MPL AND EARLY HUMAN HEMATOPOIESIS$255,503
R01 · FY2002 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$69,992
R01 · FY2002 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$248,866
R01 · FY2001 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$67,953
R01 · FY2001 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$293,161
R01 · FY2000 · DK
C-MPL AND EARLY HUMAN HEMATOPOIESIS$43,983
R01 · FY2000 · DK